TTD vs. KRYS
TTD (The Trade Desk, Inc.) and KRYS (Krystal Biotech, Inc.) are both stocks. TTD operates in Software - Application (Technology), while KRYS operates in Biotechnology (Healthcare). Over the past 5 years, TTD returned -19.79%/yr vs 35.77%/yr for KRYS. At a 0.26 correlation, their price movements are largely independent.
Performance
TTD vs. KRYS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TTD achieves a -48.81% return, which is significantly lower than KRYS's 22.40% return.
TTD
- 1D
- -2.61%
- 1M
- -15.81%
- YTD
- -48.81%
- 6M
- -50.62%
- 1Y
- -72.81%
- 3Y*
- -36.13%
- 5Y*
- -19.79%
- 10Y*
- —
KRYS
- 1D
- 0.25%
- 1M
- -1.29%
- YTD
- 22.40%
- 6M
- 28.93%
- 1Y
- 120.36%
- 3Y*
- 32.77%
- 5Y*
- 35.77%
- 10Y*
- —
TTD vs. KRYS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TTD The Trade Desk, Inc. | -48.81% | -67.70% | 63.33% | 60.52% | -51.08% | 14.41% | 208.34% | 123.83% | 153.79% | -25.91% |
KRYS Krystal Biotech, Inc. | 22.40% | 57.37% | 26.28% | 56.60% | 13.25% | 16.58% | 8.34% | 166.51% | 97.53% | 0.19% |
Correlation
The correlation between TTD and KRYS is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Sep 20, 2017 | 0.26 |
The correlation between TTD and KRYS shifts across timeframes, from 0.07 (1 year) to 0.28 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
TTD:
$9.27B
KRYS:
$9.21B
TTD:
$0.89
KRYS:
$7.50
TTD:
21.88
KRYS:
40.24
TTD:
0.29
KRYS:
0.10
TTD:
3.19
KRYS:
21.70
TTD:
3.78
KRYS:
7.21
TTD:
$2.97B
KRYS:
$417.30M
TTD:
$2.31B
KRYS:
$387.24M
TTD:
$725.01M
KRYS:
$185.45M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TTD vs. KRYS — Risk / Return Rank
TTD
KRYS
TTD vs. KRYS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for The Trade Desk, Inc. (TTD) and Krystal Biotech, Inc. (KRYS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TTD | KRYS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -4.26 | ||
| Sortino ratioReturn per unit of downside risk | -5.41 | ||
| Omega ratioGain probability vs. loss probability | 0.71 | 1.47 | -0.75 |
| Calmar ratioReturn relative to maximum drawdown | -0.93 | 7.59 | -8.52 |
| Martin ratioReturn relative to average drawdown | -1.30 | 19.64 | -20.94 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TTD | KRYS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.14 | 3.12 | -4.26 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.30 | 0.47 | -0.77 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | 0.63 | -0.32 |
Drawdowns
TTD vs. KRYS - Drawdown Comparison
The maximum TTD drawdown since its inception was -86.07%, which is greater than KRYS's maximum drawdown of -53.42%. Use the drawdown chart below to compare losses from any high point for TTD and KRYS.
Loading charts...
Drawdown Indicators
| TTD | KRYS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.07% | -53.42% | -32.65% |
Max Drawdown (1Y)Largest decline over 1 year | -78.35% | -15.94% | -62.41% |
Max Drawdown (3Y)Largest decline over 3 years | -86.07% | -42.26% | -43.81% |
Max Drawdown (5Y)Largest decline over 5 years | -86.07% | -44.55% | -41.52% |
Current DrawdownCurrent decline from peak | -86.07% | -4.60% | -81.47% |
Average DrawdownAverage peak-to-trough decline | -27.19% | -16.20% | -10.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 55.98% | 6.15% | +49.83% |
Volatility
TTD vs. KRYS - Volatility Comparison
The Trade Desk, Inc. (TTD) has a higher volatility of 19.61% compared to Krystal Biotech, Inc. (KRYS) at 10.25%. This indicates that TTD's price experiences larger fluctuations and is considered to be riskier than KRYS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TTD | KRYS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.61% | 10.25% | +9.36% |
Volatility (6M)Calculated over the trailing 6-month period | 41.01% | 27.29% | +13.72% |
Volatility (1Y)Calculated over the trailing 1-year period | 64.21% | 38.91% | +25.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.36% | 76.38% | -9.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 68.47% | 74.19% | -5.72% |
Dividends
TTD vs. KRYS - Dividend Comparison
Neither TTD nor KRYS has paid dividends to shareholders.
Financials
TTD vs. KRYS - Financials Comparison
This section allows you to compare key financial metrics between The Trade Desk, Inc. and Krystal Biotech, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TTD vs. KRYS - Profitability Comparison
TTD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Trade Desk, Inc. reported a gross profit of 506.89M and revenue of 688.86M. Therefore, the gross margin over that period was 73.6%.
KRYS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Krystal Biotech, Inc. reported a gross profit of 110.03M and revenue of 116.36M. Therefore, the gross margin over that period was 94.6%.
TTD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Trade Desk, Inc. reported an operating income of 66.65M and revenue of 688.86M, resulting in an operating margin of 9.7%.
KRYS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Krystal Biotech, Inc. reported an operating income of 53.69M and revenue of 116.36M, resulting in an operating margin of 46.1%.
TTD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Trade Desk, Inc. reported a net income of 40.00M and revenue of 688.86M, resulting in a net margin of 5.8%.
KRYS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Krystal Biotech, Inc. reported a net income of 55.93M and revenue of 116.36M, resulting in a net margin of 48.1%.
Frequently Asked Questions
TTD and KRYS have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TTD has higher volatility (19.61%) compared to KRYS (10.25%). In terms of maximum drawdown, TTD dropped -86.07% vs KRYS's -53.42%.
KRYS currently has the higher Sharpe Ratio (3.12 vs -1.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TTD and KRYS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer